LS
TEVA icon

Leelyn Smith’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Leelyn Smith’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$2K – 387
2021
Q1 		$2K Hold
200
– – ﹤0.01% 359
2020
Q4 		$2K Buy
+200
New +$1.92K ﹤0.01% 335

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Leelyn Smith's TEVA Position: Q2 2021 in Review

Leelyn Smith sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2021, closing a stake of 200 shares — an estimated $2K sold.

Leelyn Smith first reported a position in TEVA in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Leelyn Smith reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2021 after selling out during the quarter.
  • Leelyn Smith sold 200 Teva Pharmaceutical Industries Limited shares in Q2 2021, an estimated $2K.
  • Leelyn Smith first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 2 quarters.
  • Leelyn Smith's Teva Pharmaceutical Industries Limited position peaked at $2K in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2021.

Based on Leelyn Smith's 13F filing for Q2 2021, filed 31 Aug 2021.